• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
The evolution of the regulatory framework for the plasma and plasma-derived medicinal products system in Italy.意大利血浆及血浆衍生药品体系监管框架的演变
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s6-12. doi: 10.2450/2013.003s.
2
Plasma-derived medicinal products in Italy: information sources and flows.意大利的血浆源性药品：信息来源与流通
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s13-7. doi: 10.2450/2013.004s.
3
[Guidelines on the use of medicinal plants].[药用植物使用指南]
Boll Chim Farm. 1978 May;117(5):251-7.
4
[The new norms decreed by the legislative dirrective 91-93 CCE].
Boll Chim Farm. 1998 Feb;137(2):31-4.
5
[The problem of pesticide and heavy metal residues in plant-derived drugs used in the pharmaceutical industry].[制药行业中植物源药物的农药和重金属残留问题]
Nuovi Ann Ig Microbiol. 1985 May-Jun;36(3):169-80.
6
Plasma-derived medicinal products self-sufficiency from national plasma: to what extent?国家血浆来源的血浆衍生药品自给自足情况：程度如何？
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s132-7. doi: 10.2450/2013.019s.
7
Regulatory status of medicinal products for human beings in the European Union. The role of generic products.欧盟人用药品的监管状况。仿制药的作用。
Pharmacol Res. 1996 Jul-Aug;34(1-2):3-7. doi: 10.1006/phrs.1996.0055.
8
[The regulatory framework for complementary and alternative medicines in Europe].[欧洲补充和替代医学的监管框架]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Jul;51(7):771-8. doi: 10.1007/s00103-008-0584-8.
9
[Pharmaceutical specialities: definitions and rules for manufacturing and marketing in Italy].
Boll Chim Farm. 1979 Mar;118(3):135-43.
10
[New pharmaceutical legislation in Italy and Federal Republic of Germany in relation to European Economic Community directives].[意大利和德意志联邦共和国与欧洲经济共同体指令相关的新药品立法]
Boll Chim Farm. 1979 Mar;118(3):144-62.

引用本文的文献

1
Use of fresh-frozen plasma in 2012 at the Fondazione Ca' Granda Hospital of Milan: assessment of appropriateness using record linkage techniques applied to data routinely recorded in various hospital information systems.2012 年米兰圣拉斐尔科学研究所附属医院新鲜冰冻血浆的使用：使用记录链接技术对不同医院信息系统中常规记录的数据进行适宜性评估。
Blood Transfus. 2018 May;16(3):253-261. doi: 10.2450/2017.0309-16. Epub 2017 Jun 19.
2
Present and future challenges in the treatment of haemophilia: the patient's perspective.血友病治疗中的当前与未来挑战：患者视角
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s82-5. doi: 10.2450/2013.013s.
3
The demand for factor VIII and for factor IX and the toll fractionation product surplus management.对凝血因子 VIII、凝血因子 IX 的需求以及凝血因子浓缩物产品过剩管理。
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s64-76. doi: 10.2450/2013.011s.
4
Plasma-derived medicinal products: demand and clinical use.血浆衍生药物产品：需求与临床应用。
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s2-5. doi: 10.2450/2013.002s.
5
Plasma-derived medicinal products in Italy: information sources and flows.意大利的血浆源性药品：信息来源与流通
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s13-7. doi: 10.2450/2013.004s.
6
Plasma and plasma-derived medicinal product self-sufficiency: the Italian case.血浆及血浆衍生药品的自给自足：意大利的情况
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s118-31. doi: 10.2450/2013.018s.

本文引用的文献

1
Plasma-derived medicinal products in Italy: information sources and flows.意大利的血浆源性药品：信息来源与流通
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s13-7. doi: 10.2450/2013.004s.
2
Production of plasma-derived medicinal products: ethical implications for blood donation and donors.血浆衍生药品的生产：对献血及献血者的伦理影响
Blood Transfus. 2014 Jan;12 Suppl 1(Suppl 1):s389-94. doi: 10.2450/2013.0167-12. Epub 2013 Feb 21.
3
The Dublin Consensus Statement 2011 on vital issues relating to the collection and provision of blood components and plasma-derived medicinal products.《2011年都柏林关于血液成分及血浆衍生药品采集与供应相关重大问题的共识声明》
Vox Sang. 2012 Feb;102(2):140-3. doi: 10.1111/j.1423-0410.2011.01528.x. Epub 2011 Aug 1.
4
Plasma fractionation issues.血浆分离问题。
Biologicals. 2009 Apr;37(2):88-93. doi: 10.1016/j.biologicals.2009.01.005. Epub 2009 Mar 16.
5
West Nile virus in Italy: a further threat to blood safety, a further challenge to the blood system.意大利的西尼罗河病毒：对血液安全的又一威胁，对血液系统的又一挑战。
Blood Transfus. 2008 Oct;6(4):235-7. doi: 10.2450/2008.0065-08.
6
The Chikungunya epidemic in Italy and its repercussion on the blood system.意大利的基孔肯雅热疫情及其对血液系统的影响。
Blood Transfus. 2008 Oct;6(4):199-210. doi: 10.2450/2008.0016-08.
7
Clinical appropriateness of blood component transfusion: regulatory requirements and standards set by the Scientific Society in Italy.血液成分输血的临床适宜性：意大利科学协会制定的监管要求和标准
Blood Transfus. 2008 Oct;6(4):186-90. doi: 10.2450/2008.0049-07.

The evolution of the regulatory framework for the plasma and plasma-derived medicinal products system in Italy.

作者信息

Calizzani Gabriele, Vaglio Stefania, Candura Fabio, Profili Samantha, Lanzoni Monica, Cristiano Karen, Tamburrini Maria Rita, Grazzini Giuliano, Oleari Fabrizio

机构信息

Italian National Blood Centre, National Institute of Health, Rome, Italy.

Italian National Blood Centre, National Institute of Health, Rome, Italy Faculty of Medicine and Psychology "Sapienza" University of Rome, Rome, Italy.

出版信息

Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s6-12. doi: 10.2450/2013.003s.

DOI:10.2450/2013.003s
PMID:24333315
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3853985/
Abstract
摘要